Search Results - "Rivas-Rivas C"

Laryngeal involvement in a patient with indolent T-cell lymphoproliferative disorder of the gastrointestinal tract.

Authors: Morales-Angulo C Rivas-Rivas C González de Villambrosia Pellón S

Source: Acta otorrinolaringologica espanola [Acta Otorrinolaringol Esp (Engl Ed)] 2026 Mar-Apr; Vol. 77 (2), pp. 512314. Date of Electronic Publication: 2025 Dec 05.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier España Country of Publication: Spain NLM ID: 101770938 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2173-5735 (Electronic) Linking ISSN: 21735735 NLM ISO Abbreviation: Acta Otorrinolaringol Esp (Engl Ed) Subsets: MEDLINE; In Process

MASLD Management in Spain: A Nationwide Survey of Gastroenterologists Highlighting Gaps in Risk Assessment and Primary Care Coordination.

Authors: Jiménez-González, Carolina Argos Vélez, Paula Cayón, Lorena et al.

Source: Journal of Clinical Medicine. May2026, Vol. 15 Issue 9, p3259. 12p.

Obesity-Mediated Inflammation and Its Influence on Inflammatory Bowel Disease: Pathophysiology, Clinical Impact, and Therapeutic Implications.

Authors: Casas-Deza, Diego García-López, Santiago Bernal-Monterde, Vanesa et al.

Source: Biomolecules (2218-273X). Aug2025, Vol. 15 Issue 8, p1185. 18p.

Lean MASLD and IBD: Exploring the Intersection of Metabolic Dysfunction and the Gut–Liver Axis.

Authors: Rotaru, Adrian Stafie, Remus Stratina, Ermina et al.

Source: Life (2075-1729). Feb2025, Vol. 15 Issue 2, p288. 16p.

Inflammatory Bowel Diseases and Non-Alcoholic Fatty Liver Disease: Piecing a Complex Puzzle Together.

Authors: Maresca, Rossella Mignini, Irene Varca, Simone et al.

Source: International Journal of Molecular Sciences. Mar2024, Vol. 25 Issue 6, p3278. 16p.

Metabolic Dysfunction-Associated Steatotic Liver Disease in Patients with Inflammatory Bowel Diseases: A Pilot Study.

Authors: Abenavoli, Ludovico Spagnuolo, Rocco Scarlata, Giuseppe Guido Maria et al.

Source: Life (2075-1729). Oct2024, Vol. 14 Issue 10, p1226. 11p.

Exploring the role of gut microbiota in inflammatory bowel disease patients comorbid with non-alcoholic fatty liver disease.

Authors: Hu, Jiachen Zhou, Chen Zhang, Lu et al.

Source: Gut Pathogens. 10/15/2025, Vol. 17 Issue 1, p1-15. 15p.

Global epidemiology of type 2 diabetes in patients with NAFLD or MAFLD: a systematic review and meta-analysis.

Authors: Cao, Limin An, Yu Liu, Huiyuan et al.

Source: BMC Medicine. 3/7/2024, Vol. 22 Issue 1, p1-22. 22p.

Use of Metabolic Scores and Lipid Ratios to Predict Metabolic Dysfunction-Associated Steatotic Liver Disease Onset in Patients with Inflammatory Bowel Diseases.

Authors: Abenavoli, Ludovico Scarlata, Giuseppe Guido Maria Borelli, Massimo et al.

Source: Journal of Clinical Medicine. May2025, Vol. 14 Issue 9, p2973. 16p.

Metabolic Dysfunction-Associated Fatty Liver Disease in Taiwanese Patients with Inflammatory Bowel Disease: A Study in Patients with Clinical Remission.

Authors: Hsiao, Shun-Wen Chen, Ting-Chun Su, Pei-Yuan et al.

Source: Diagnostics (2075-4418). Oct2023, Vol. 13 Issue 20, p3268. 11p.

Liver Fibrosis in Non-Alcoholic Fatty Liver Disease and Progression to Hepatocellular Carcinoma in Patients with Inflammatory Bowel Disease: A Systematic Review.

Authors: Martínez-Domínguez, Samuel J. García-Mateo, Sandra Laredo, Viviana et al.

Source: Cancers. Jul2023, Vol. 15 Issue 13, p3367. 13p.

Type 2 Diabetes Mellitus in Inflammatory Bowel Disease Patients: A Case–Control Study Through a Long Follow-Up Period.

Authors: Zaccardi, Benedetta Armandi, Angelo Caviglia, Gian Paolo et al.

Source: Journal of Clinical Medicine. Jan2025, Vol. 14 Issue 1, p143. 17p.

Screening for Liver Steatosis and Fibrosis in Patients with Inflammatory Bowel Disease Using Vibration Controlled Transient Elastography with Controlled Attenuation Parameter.

Authors: Trifan, Anca Stafie, Remus Rotaru, Adrian et al.

Source: Journal of Clinical Medicine. Oct2022, Vol. 11 Issue 19, p5959. 11p.

Identifying inflammatory bowel disease patients at risk of metabolic dysfunction-associated fatty liver disease: usefulness of non-invasive steatosis predictive scores.

Authors: Capela, Tiago Lima Silva, Vítor Macedo Freitas, Marta et al.

Source: BMC Gastroenterology. 12/13/2023, Vol. 23 Issue 1, p1-14. 14p.

Innovative Therapeutic Approaches in Non-Alcoholic Fatty Liver Disease: When Knowing Your Patient Is Key.

Authors: Alonso-Peña, Marta Del Barrio, Maria Peleteiro-Vigil, Ana et al.

Source: International Journal of Molecular Sciences. Jul2023, Vol. 24 Issue 13, p10718. 28p.

Smoking and liver diseases: an updated review of pathogenesis, progression, and therapeutic implications.

Authors: El-Azab G Elkhouly E Abouyoussef R et al.

Source: Clinical and experimental medicine [Clin Exp Med] 2025 Dec 03; Vol. 26 (1), pp. 51. Date of Electronic Publication: 2025 Dec 03.

Publication Type: Journal Article; Review

Journal Info: Publisher: Springer-Verlag Italia Country of Publication: Italy NLM ID: 100973405 Publication Model: Electronic Cited Medium: Internet ISSN: 1591-9528 (Electronic) Linking ISSN: 15918890 NLM ISO Abbreviation: Clin Exp Med Subsets: MEDLINE

Exploring shared pathogenic mechanisms and biomarkers in hepatic fibrosis and inflammatory bowel disease through bioinformatics and machine learning.

Authors: Li S Li H Qi M

Source: Frontiers in immunology [Front Immunol] 2025 May 12; Vol. 16, pp. 1533246. Date of Electronic Publication: 2025 May 12 (Print Publication: 2025).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

National digestive disease specialists survey on cardiovascular risk management in non-alcoholic fatty liver disease in spanish hospitals.

Authors: Iruzubieta P Arias-Loste MT Fortea JI et al.

Source: Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2021 Jun; Vol. 41 (6), pp. 1243-1253. Date of Electronic Publication: 2021 Feb 16.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 101160857 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1478-3231 (Electronic) Linking ISSN: 14783223 NLM ISO Abbreviation: Liver Int Subsets: MEDLINE

MAFLD as part of systemic metabolic dysregulation.

Authors: Zhao J Liu L Cao YY et al.

Source: Hepatology international [Hepatol Int] 2024 Oct; Vol. 18 (Suppl 2), pp. 834-847. Date of Electronic Publication: 2024 Apr 09.

Publication Type: Journal Article; Review

Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 101304009 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1936-0541 (Electronic) Linking ISSN: 19360533 NLM ISO Abbreviation: Hepatol Int Subsets: MEDLINE

Comparisons of global incidence and risk factor profiles of hepatocellular carcinoma and intrahepatic cholangiocarcinoma.

Authors: Wu T Du M Zhang T et al.

Source: Annals of hepatology [Ann Hepatol] 2026 Jan-Jun; Vol. 31 (1), pp. 102139. Date of Electronic Publication: 2025 Oct 11.

Publication Type: Journal Article; Comparative Study

Journal Info: Publisher: Fundación Clínica Médica Sur Country of Publication: Mexico NLM ID: 101155885 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1665-2681 (Print) Linking ISSN: 16652681 NLM ISO Abbreviation: Ann Hepatol Subsets: MEDLINE